Insights into Company Bills & Payments

Jindal Steel ↗

📍 Hisar, Haryana, Global Active NSE JINDALSTEL CIN L27105HR1979PLC009913 Steel
Search companies

Key Metrics of Jindal Steel

Revenue₹54,023 Cr▲ 10.7% YoYFY 2025-26
EBITDA₹7,295 Cr▼ 5.7% YoY
Net profit₹3,074 Cr▼ 15.1% YoY
Net worth₹53,130 Cr▲ 6.8% YoY
Competitors10identified

About Jindal Steel

Sectors

Steel, Metals & PipesTMT Bars & Secondary Steel

Company details

Website
jindalsteel.com
Registered office
O.p. Jindal Marg, Hisar, In-hr, 125005
Listed
NSE: JINDALSTEL · ₹1,105.00

Operational Areas of Jindal Steel

Steel, Metals & Pipes›TMT Bars & Secondary Steel

Company summary

Entity details

CINL27105HR1979PLC009913
LEI code335800UIKQBF6QO2NP15
State codeHR
PIN code125005
Current legal nameJINDAL STEEL
Classification—
Listing statusListed (NSE: JINDALSTEL)
Registration no.009913
Company age—
PAN—
CountryGlobal
CityHisar
StateHaryana
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code27105
Description of main activityManufacture of basic metals (iron, steel, non-ferrous, casting)
Description of business activityManufacture of basic metals (iron, steel, non-ferrous, casting)
SectorSteel

Share price · NSE: JINDALSTEL

JINDALSTEL on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 25 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

ICRA · 22 Oct 2026 ICRA AA+ Stable outlook · Short term A1+ · Reaffirmed
CARE · 12 Oct 2026 CARE AA+ Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 months▲ 1 notch
Change since first rating on record▲ 8 notchessince Feb 2019
Rating actions222 up · 0 down
Liquidity (ICRA)Adequate

PositiveUpgraded by ICRA on 04 Aug 2026

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
22 Oct 2026ICRAReaffirmed AA+A1+Stable₹40,200 Cr View
12 Oct 2026CAREReaffirmed AA+A1+Stable₹40,225 Cr View
04 Aug 2026ICRAUpgraded AA+A1+Stable₹40,000 Cr View
07 Jul 2026CAREUpgraded (from AA) AA+A1+Stable₹40,025 Cr View
09 Oct 2025CAREReaffirmed AAA1+Stable₹40,025 Cr View
07 Apr 2025CAREReaffirmed AAA1+Stable₹40,025 Cr View
13 Jan 2025CAREReaffirmed AAA1+Stable₹40,000 Cr View
28 Aug 2024CAREOther ———— View
04 Apr 2024CAREReaffirmed AAA1+Stable₹40,000 Cr View
27 Oct 2023CAREReaffirmed (from AA-) AAA1+Stable₹40,000 Cr View
28 Mar 2023CAREReaffirmed AA-A1+Positive₹35,000 Cr View
06 Jan 2023CAREReaffirmed AA-A1+Stable₹35,000 Cr View
10 Oct 2022CAREReaffirmed AA-A1+Stable₹59,698 Cr View
13 Dec 2021CAREReaffirmed (from AA-) A+A1+Stable₹59,698 Cr View
06 Jul 2021CARERevised (from A-) A+A1+Stable₹0 View
06 May 2021CAREReaffirmed A-A2+Stable₹50,976 Cr View
01 Apr 2021CARERevised —A2+Stable₹50,976 Cr View
30 Dec 2020CARERevised (from BBB-) BBB+A2Stable₹520 Cr View
06 Jul 2020CAREWatch BBBA3Stable₹24,971 Cr View
17 Apr 2020CAREWatch BBB-A3—₹25,170 Cr View
30 Aug 2019CAREReaffirmed BBB-A3Stable₹25,170 Cr View
08 Feb 2019CAREReaffirmed BBB-A3Stable₹25,002 Cr View

Credit strengths (ICRA, Oct 2026)

+ Significant improvement expected in consolidated sales volume and profits to support Jindal Steel’s credit profile

JSOL, the wholly-owned subsidiary of Jindal Steel, successfully commissioned its steel manufacturing facilities in March 2026, enhancing the Group’s steel-making capacity to 15.6 mtpa from 9.6 mtpa.

+ Strong financial risk profile with healthy leverage and coverage indicators

The higher scale of operation and an expected OPBDITA/tonne of >Rs. 11,000 per MT are likely to support comfortable credit metrics for the company with an estimated net debt/OPBDITA of ~1.5 times in FY2027.

+ Cost competitiveness arising from large-scale integrated operations and attractive plant locations

Jindal Steel manufacturing operations are vertically integrated, encompassing captive iron ore mines for partial capacity, captive thermal coal mines, coal washing, coke manufacturing, pelletisation, sponge iron manufacturing, power generation and production of semi and finished steel products.

+ Better raw material security through enhanced production

The ratings continue to derive comfort from Jindal Steel’s increasing backward integration and strengthening raw material security, supported by the operationalisation and ramp-up of multiple captive mining assets.

+ Established track record and diversified operations with forward integration into value-added products

Jindal Steel has an established track record in successfully commissioning greenfield/brownfield capacities in the steel and power segments as well as in operating its plants at healthy capacity utilisation.

Credit challenges

− Inherent vulnerability of steel business to volatility in metal prices

Jindal Steel operates in a cyclical industry with global overcapacity.

− Susceptibility of profitability to volatility in raw material prices

While the company’s raw material coverage has improved over the years, its profitability remains susceptible to the volatility in raw material requirements as it remains dependent on external purchases for a part of its coking coal and iron ore requirements.

− Exposure to regulatory risks

The ratings remain constrained by the company’s exposure to regulatory and policy-related risks inherent in the steel and the mining sectors.

Could lead to an upgrade

ICRA could upgrade the company’s rating if it demonstrates a significant growth in its operating income and profitability, along with strong

Could lead to a downgrade

Pressure on the ratings could emerge in case of a sustained deterioration in earnings, or if any sizeable debt-funded capex/investment/acquisition results in an increase in the net debt/OPBDITA of more than 2.0 times on a sustained basis.

Agency-reported financials (ICRA, 22 Oct 2026)

MetricFY2025FY2026
Operating income (OI)₹49,765 Cr₹53,225 Cr
PAT₹2,855 Cr₹3,376 Cr
OPBDIT/OI18.7%17.1%
PAT/OI5.7%6.3%
Total outside liabilities/Tangible net worth (times)0.80×0.90×
Total debt/OPBDIT (times)2.00×2.50×
Interest coverage (times)6.10×5.30×
Revenue growth (YoY)—7.0%
EBITDA (margin × income)₹9,306 Cr₹9,101 Cr
Implied total debt (debt/EBITDA × EBITDA)₹18,612 Cr₹22,754 Cr
Implied interest cost (EBITDA ÷ coverage)₹1,526 Cr₹1,717 Cr

Borrowings & rated debt

Rated borrowing limits (latest)₹40,225 Cr
Peak rated limits₹59,698 CrDec 2021 · CARE
Limits raised1 time3 new facilities rated
Weighted average coupon9.80%

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹18,385 Cr— AA+ (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹16,840 Cr— A1+ReaffirmedCARE
Non-convertible debenturesDebentures & bonds—₹5,000 Cr— AA+ (Stable)ReaffirmedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE749A07185OctDebentures & bonds9.80% —— ₹50.0 CrBBB- Not stated
INE749A07383JanDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07367FebDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07342MarDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07177OctDebentures & bonds9.80% —— —BBB- Not stated
INE749A07326NovDebentures & bonds9.80% —— —BBB- Not stated
INE749A07227DecDebentures & bonds9.80% —— —BBB- Not stated
INE749A07391JanDebentures & bonds9.80% —— —BBB- Not stated
INE749A07193OctDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07334NovDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07359DecDebentures & bonds9.80% —— ₹75.0 CrBBB- Not stated
INE749A07284Jan watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07300Feb watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07318Mar watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07151Aug watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07169Sep watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07201Nov watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07250Jan watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07219Nov watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A07268Dec watch withDebentures & bonds9.80% —— —BBB- Not stated
INE749A08126Aug watch withDebentures & bonds10.48% —— —BBB- Not stated
—p.a.Debentures & bonds9.80% 29 Dec 200929 Dec 2021 ₹24.8 CrA- Matured
—Debentures Non paDebentures & bonds9.80% 24 Aug 200929 Dec 2021 ₹160 CrBBB- Matured
—Debentures NonDebentures & bonds9.80% 24 Aug 200929 Dec 2021 ₹250 CrBBB- Matured
—Debentures Non p.a.Debentures & bonds9.80% 29 Dec 200929 Dec 2021 ₹24.8 CrBBB- Matured
—Debentures Non pa Under CreditDebentures & bonds9.80% 24 Aug 200929 Dec 2021 ₹500 CrBBB- Matured
—Debentures Non Under CreditDebentures & bonds9.80% 24 Aug 200929 Dec 2021 ₹710 CrBBB- Matured
—Debentures Non p.a. Under CreditDebentures & bonds9.80% 29 Dec 200929 Dec 2021 ₹37.2 CrBBB- Matured
—paDebentures & bonds9.80% 25 Jan 201026 Mar 2021 ₹200 CrA- Matured
—p.a.Debentures & bonds9.80% 24 Nov 200925 Jan 2021 ₹175 CrA- Matured
—p.a.Debentures & bonds9.80% 09 Nov 200908 Jan 2021 ₹120 CrA- Matured
—Debentures Non paDebentures & bonds9.80% 26 Mar 201028 Dec 2020 ₹200 CrBBB- Matured
—Debentures Non paDebentures & bonds9.80% 12 Oct 200912 Apr 2020 ₹50.0 CrBBB- Matured
—Debentures Non pa Under CreditDebentures & bonds9.80% 12 Oct 200912 Apr 2020 ₹100 CrBBB- Matured
—FYTerm loans— —31 Mar 2015 ₹18,285 CrAA+ Matured
—FYTerm loans— —31 Mar 2015 ₹16,760 CrAA+ Matured
INE749A07466JanDebentures & bonds9.80% —— ₹10.0 Cr— Withdrawn
INE749A07458FebDebentures & bonds9.80% —— ₹10.0 Cr— Withdrawn
INE749A07433MarDebentures & bonds9.80% —— ₹10.0 Cr— Withdrawn
INE749A07417NovDebentures & bonds9.80% —— ₹9.00 Cr— Withdrawn

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LC₹16,840 CrCARE A1+
Cash Credit₹1,600 CrCARE AA+; Stable
Commercial Paper—Withdrawn
Letter of credit—Withdrawn
Non Convertible Debentures—Withdrawn
Non Convertible Debentures₹5,000 CrCARE AA+; Stable
Term Loan—Withdrawn
Term Loan₹16,785 CrCARE AA+; Stable
Working Capital Limits—Withdrawn

Lenders

Fund-based - LTCash CreditAxis Bank Ltd.
Fund-based - LTCash CreditHDFC Bank Ltd.
Fund-based - LTCash CreditICICI Bank Ltd.
Fund-based - LTCash CreditIndusInd Bank Ltd.
Fund-based - LTCash CreditPunjab National Bank
Fund-based - LTCash CreditStandard Chartered Bank
Fund-based - LTCash CreditState Bank of India
Fund-based - LTCash CreditYes Bank Ltd.
Fund-based - LTTerm LoanAxis Bank Ltd.
Fund-based - LTTerm LoanCanara Bank
Fund-based - LTTerm LoanExport Import Bank of India
Fund-based - LTTerm LoanHDFC Bank Ltd.
Fund-based - LTTerm LoanIDBI Bank Ltd.
Fund-based - LTTerm LoanIndusInd Bank Ltd.
Fund-based - LTTerm LoanProposed
Fund-based - LTTerm LoanState Bank of India
Non-fund-based - STBG/LCAxis Bank Ltd.
Non-fund-based - STBG/LCHDFC Bank Ltd.
Non-fund-based - STBG/LCICICI Bank Ltd.
Non-fund-based - STBG/LCIndusInd Bank Ltd.
Non-fund-based - STBG/LCProposed
Non-fund-based - STBG/LCPunjab National Bank
Non-fund-based - STBG/LCStandard Chartered Bank
Non-fund-based - STBG/LCState Bank of India
Non-fund-based - STBG/LCYes Bank Ltd.

Credit assessment · Iron & steel

ICRA Rating Methodology – Iron & Steel (Jun 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrongAgency: Adequate
DirectionRating watch – DevelopingAgency outlook: Stable
ICRA rating · Oct 2026AA+2 notches above indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)61%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding likely Next rating action stable or better: 63% (Mostly stable) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹40,200 Cr
Not yet allocated₹175 Cr
Extra debt within 3.5× EBITDA—
Interest coverage5.30×
Limit utilisation30%
Open bank charges0 · —
  • Credit outlook model: 63% chance the next rating action is stable or better
  • Current rating AA+ (investment grade)
  • Interest coverage 5.3×
  • Working-capital limits 30% utilised on average
  • ₹175 cr of rated limits not yet tied to a lender

What happened, step by step

Refinanced bank debt with equity
  1. Jul 2021 — Full repayment of NCD
  2. Dec 2021 — ₹673 cr raised through equity

“The promoters of the company have demonstrated their support in the form of regular equity infusions; by way of issue of share warrants of Rs.673 crore to the promoters (issued in FY18 with 25% upfront receipt and converted into equity share in FY20 with receipt of remaining 75%) and fresh equity infusion of Rs.20crore...”

Refinanced bank debt with equity from JSPL
  1. Jul 2021 — Full repayment of NCD
  2. Dec 2021 — ₹1,800 cr raised through equity from JSPL

“The company has incurred total cost of Rs.1,800 crore till November 24, 2021 by way of equity infusion from JSPL and Capex LC issuance.”

Rated limits by facility

Timeline

22 Oct 2026 ICRA reaffirmed: AA+ (Stable)Rated limits ₹40,200 cr ICRA rationale
22 Oct 2026 New borrowing arranged (NCDs / bonds)
From the report

Long-term – Fund-based – Term 16,759.95 18,285.00 reaffirmed/assigned for RBI loan enhanced amount Short-term – Non-fund based bank 16,640.05 15,140.00 [ICRA]A1+; reaffirmed RBI facilities Long-term – Unallocated limits - 175.00 [ICRA]AA+ (Stable); assigned RBI Non-convertible debentures 5,000.00 5,000.00 [ICRA]AA+ (Stable); reaffirmed SEBI (NCDs) Total 40,000.00 40,200.00 *Instrument details are provided in Annexure I # SEBI’s grievance redressal/dispute resolution and SEBI investor protection mechanisms such as SCORES and ODR shall not be ava ilable for activities and instruments, which fall

ICRA rationale
22 Oct 2026 Cash & liquid funds ₹5,605 cr
From the report

ICRA also derives comfort from Jindal Steel’s comfortable liquidity position with liquid cash balances and investment portfolio of ~Rs. 5,605 crore as on March 31, 2026.

ICRA rationale
22 Oct 2026 Cash & liquid funds ₹6,213 cr
From the report

ICRA expects Jindal Steel’s consolidated cash flow from operations of ~Rs. 6,213 crore and accumulated liquid balances to be sufficient to meet the margin requirements for its capex as well as the debt servicing requirements in the near to medium term (repayment obligations of ~Rs. 1,892 crore in FY2027).

ICRA rationale
22 Oct 2026 Debt repayments due in FY2027: ₹1,892 cr
From the report

ICRA expects Jindal Steel’s consolidated cash flow from operations of ~Rs. 6,213 crore and accumulated liquid balances to be sufficient to meet the margin requirements for its capex as well as the debt servicing requirements in the near to medium term (repayment obligations of ~Rs. 1,892 crore in FY2027).

ICRA rationale
22 Oct 2026 Average working-capital utilisation 30%
From the report

The average working capital utilisation also remained comfortable at around 30% in the last 12 months, further supporting the liquidity position .

ICRA rationale
12 Oct 2026 CARE reaffirmed: AA+ (Stable)Rated limits ₹40,225 cr CARE rationale
12 Oct 2026 Cash & liquid funds ₹6,200 cr
From the report

Liquidity is further supported by the company’s healthy cash and cash equivalents amounting to ~₹6,200 crore as on March 31, 2026.

CARE rationale
04 Aug 2026 ICRA upgraded: AA+ (Stable)Rated limits ₹40,000 cr ICRA rationale
04 Aug 2026 Cash & liquid funds ₹5,605 cr
From the report

ICRA also derives comfort from Jindal Steel’s comfortable liquidity position with liquid cash balances and investment portfolio of ~Rs. 5,605 crore as on March 31, 2026.

ICRA rationale
04 Aug 2026 Cash & liquid funds ₹6,213 cr
From the report

ICRA expects Jindal Steel’s consolidated cash flow from operations of ~Rs. 6,213 crore and accumulated liquid balances to be sufficient to meet the margin requirements for its capex as well as the debt servicing requirements in the near to medium term (repayment obligations of ~Rs. 1,892 crore in FY2027).

ICRA rationale
04 Aug 2026 Debt repayments due in FY2027: ₹1,892 cr
From the report

ICRA expects Jindal Steel’s consolidated cash flow from operations of ~Rs. 6,213 crore and accumulated liquid balances to be sufficient to meet the margin requirements for its capex as well as the debt servicing requirements in the near to medium term (repayment obligations of ~Rs. 1,892 crore in FY2027).

ICRA rationale
04 Aug 2026 Average working-capital utilisation 30%
From the report

The average working capital utilisation also remained comfortable at around 30% in the last 12 months, further supporting the liquidity position.

ICRA rationale
07 Jul 2026 CARE upgraded: AA+ (Stable)Rated limits ₹40,025 cr CARE rationale
07 Jul 2026 Cash & liquid funds ₹6,200 cr
From the report

The liquidity is further supported by the company’s healthy cash & cash equivalents amounting to ~₹6,200 crore as on March 31, 2026.

CARE rationale
09 Oct 2025 CARE reaffirmed: AA (Stable)Rated limits ₹40,025 cr CARE rationale
09 Oct 2025 Cash & liquid funds ₹5,500 cr
From the report

Liquidity: Strong The company holds a strong liquidity position which is marked by its healthy gross cash accruals (GCA) above ₹5,500 crore in FY25, which is further expected to improve with JSOL facility being operational at the optimum level from FY27 onwards.

CARE rationale
07 Apr 2025 CARE reaffirmed: AA (Stable)Rated limits ₹40,025 cr CARE rationale
07 Apr 2025 ₹19,000 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ~₹19,000 crore till December 31, 20 24, by way of equity infusion from JSPL and capex LC issuances/term loan.

CARE rationale
07 Apr 2025 Cash & liquid funds ₹8,000 cr
From the report

Liquidity : Strong The company holds a strong liquidity position which is marked by its healthy gross cash accruals (GCA)above ₹8,000 crore annually, which is further strengthened by it cash and cash equivalents (including margin money) amounting to ~₹5,000.00 crore as on December 31, 2024.

CARE rationale
13 Jan 2025 CARE reaffirmed: AA (Stable)Rated limits ₹40,000 cr CARE rationale
13 Jan 2025 ₹19,000 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ~₹19,000 crore till December 31, 2024, by way of equity infusion from JSPL and capex LC issuances/term loan.

CARE rationale
13 Jan 2025 Cash & liquid funds ₹8,000 cr
From the report

Liquidity: Strong The company holds a strong liquidity position which is marked by its healthy gross cash accruals (GCA)above ₹8,000 crore annually, which is further strengthened by it cash and cash equivalents (including margin money) amounting to ₹3,523.13 crore as on September 30, 2024.

CARE rationale
28 Aug 2024 CARE other: — CARE rationale
04 Apr 2024 CARE reaffirmed: AA (Stable)Rated limits ₹40,000 cr CARE rationale
04 Apr 2024 ₹13,500 cr raised through equity from JSPL
From the report

The company has incurred a total cost of around ₹13,500 crore up to February 29, 2024, by way of equity infusion from JSPL and capex LC issuances.

CARE rationale
04 Apr 2024 Cash & liquid funds ₹3,439 cr
From the report

Liquidity: Strong The liquidity position is marked strong with cash & cash equivalents (includes margin money) at ₹3,439 crore as on December 31, 2023 (₹5,482 crore as on March 31, 2023).

CARE rationale
04 Apr 2024 New borrowing arranged: ₹18,240 cr (term loans)
From the report

The company has a cumulative sanctioned limit of ₹18,240 crore (includes fund-based limits of ₹1,600 crore and non-fund-based limits of ₹16,640 crore) as on February 29, 2024, with an average utilisation of fund-based limits at 13%.

CARE rationale
04 Apr 2024 Average working-capital utilisation 13%
From the report

The company has a cumulative sanctioned limit of ₹18,240 crore (includes fund-based limits of ₹1,600 crore and non-fund-based limits of ₹16,640 crore) as on February 29, 2024, with an average utilisation of fund-based limits at 13%.

CARE rationale
27 Oct 2023 CARE reaffirmed: AA (Stable)Rated limits ₹40,000 cr CARE rationale
27 Oct 2023 ₹12,000 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ~ ₹12,000 crore up to September 30, 2023, by way of equity infusion from JSPL and capex LC issuances.

CARE rationale
27 Oct 2023 Cash & liquid funds ₹4,672 cr
From the report

Liquidity: Strong The liquidity position is marked strong with cash & cash equivalents (includes margin money) at ₹4,672 crore as on June 30, 2023 (₹5,482 crore as on March 31, 2023).

CARE rationale
27 Oct 2023 New borrowing arranged: ₹20,140 cr (term loans)
From the report

The company has a cumulative sanctioned limit of ₹20,140 crore (includes fund-based limits of ₹2,000 crore and non-fund-based limits of ₹18,140 crore) as on September 30, 2023, with an average utilisation of fund-based limits at 16% and non-fund-based limits at 63% for 12 months ending June 2023.

CARE rationale
27 Oct 2023 Average working-capital utilisation 16%
From the report

The company has a cumulative sanctioned limit of ₹20,140 crore (includes fund-based limits of ₹2,000 crore and non-fund-based limits of ₹18,140 crore) as on September 30, 2023, with an average utilisation of fund-based limits at 16% and non-fund-based limits at 63% for 12 months ending June 2023.

CARE rationale
28 Mar 2023 CARE reaffirmed: AA- (Positive)Rated limits ₹35,000 cr CARE rationale
28 Mar 2023 Cash & liquid funds ₹3,015 cr
From the report

JSPL has completed the divestment process of Jindal Power Limited (JPL) against a cash consideration of ₹ 3,015 crore in Q1FY23, and resultantly, JPL has ceased to be a subsidiary or an associate entity of JSP L.

CARE rationale
28 Mar 2023 ₹7,116 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ₹7,116 crore up to November 30, 2022, by way of equity infusion from JSPL and capex LC issuances.

CARE rationale
28 Mar 2023 Cash & liquid funds ₹3,505 cr
From the report

The company had cash and cash equivalents of ₹3,505 crore, as on December 31, 2022.

CARE rationale
06 Jan 2023 CARE reaffirmed: AA- (Stable)Rated limits ₹35,000 cr CARE rationale
06 Jan 2023 Cash & liquid funds ₹3,015 cr
From the report

JSPL has completed the divestment process of Jindal Power Limited (JPL) against a cash consideration of ₹ 3,015 crore in Q1FY23, and resultantly, JPL has ceased to be a subsidiary or an associate entity of JSP L.

CARE rationale
06 Jan 2023 New borrowing arranged (term loans)
From the report

The total debt is expected to increase in FY23 owing to the debt to be availed to fund the ongoing capex in Jindal Steel Odisha Limited (JSOL).

CARE rationale
06 Jan 2023 Cash & liquid funds ₹3,830 cr
From the report

The company had cash and cash equivalents of ₹3,830 crore as on March 31, 2022.

CARE rationale
06 Jan 2023 Cash & liquid funds ₹6,440 cr
From the report

The cash and cash equivalents as on September 30, 2022, stood at ₹ 6,440 crore.

CARE rationale
06 Jan 2023 ₹7,116 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ₹7,116 crore up to November 30, 2022, by way of equity infusion from JSPL and capex LC issuances.

CARE rationale
10 Oct 2022 CARE reaffirmed: AA- (Stable)Rated limits ₹59,697.82 cr CARE rationale
10 Oct 2022 Cash & liquid funds ₹3,015 cr
From the report

JSPL has completed the divestment process of Jindal Power Limited (JPL) against a cash consideration of ₹ 3,015 crore in Q1FY23, and resultantly, JPL has ceased to be a subsidiary or an associate entity of JSPL .

CARE rationale
10 Oct 2022 New borrowing arranged (term loans)
From the report

The TD is expected to increase in FY23 owing to the debt availed to fund the ongoing capex in Jindal Steel Odisha Limited (JSOL).

CARE rationale
10 Oct 2022 Debt repayments due: ₹2,516 cr
From the report

The envisaged cash accruals for FY23, supported by cash and cash equivalents available at the beginning of FY23, are adequate to cover its scheduled debt repayment obligations of ₹2,516 crore (including current portion of lease liabilities).

CARE rationale
10 Oct 2022 Cash & liquid funds ₹3,830 cr
From the report

It had cash and cash equivalents of ₹3,830 crore as on March 31, 2022.

CARE rationale
10 Oct 2022 ₹6,777 cr raised through equity from JSPL
From the report

The company has incurred a total cost of ₹6,777 crore up to September 15, 2022, by way of equity infusion from JSPL and capex LC issuance.

CARE rationale
13 Dec 2021 CARE reaffirmed: A+ (Stable)Rated limits ₹59,697.82 cr CARE rationale
13 Dec 2021 Cash & liquid funds ₹3,015 cr
From the report

The ratings also take cognizance of JSPL bagging Kasia iron ore mine in recent auctions and commencement of Russel Vale coking coal mining in Australia thereby strengthening the company’s raw material security and shareholder’s approval for modified terms of JPL divestments which entails a reduction in consolidated debt, extinguishment of liabilities related to ICDs and advances, besides cash consideration of about Rs.3,015 crore.

CARE rationale
13 Dec 2021 ₹673 cr raised through equity
From the report

The promoters of the company have demonstrated their support in the form of regular equity infusions; by way of issue of share warrants of Rs.673 crore to the promoters (issued in FY18 with 25% upfront receipt and converted into equity share in FY20 with receipt of remaining 75%) and fresh equity infusion of Rs.20crore and company also raised equity through a qualified institutional placement (QIP) in FY18 of Rs.1,200 crore.

CARE rationale
13 Dec 2021 ₹1,800 cr raised through equity from JSPL
From the report

The company has incurred total cost of Rs.1,800 crore till November 24, 2021 by way of equity infusion from JSPL and Capex LC issuance.

CARE rationale
13 Dec 2021 Debt repayments due: ₹6,803 cr
From the report

The projected cash accruals for FY22 supported by cash & cash equivalents available at the beginning of FY22 are adequate to cover its scheduled repayment obligation of Rs.6,803 crore.

CARE rationale
13 Dec 2021 Cash & liquid funds ₹4,844 cr
From the report

It has cash and cash equivalents of Rs.4,844 crore as on September 30, 2021.

CARE rationale
06 Jul 2021 CARE revised: A+ (Stable) CARE rationale
06 Jul 2021 Full repayment of NCD
From the report

The proposed sale is subject to necessary approval of shareholders of the companies, regulatory approvals, approval from lenders of JSPL and JPL, contractual approvals and other approvals, consents, permissions and sanctions as may be necessary in line with the extant relevant guidelines. 1 Complete definition of the ratings assigned are available at www.careratings.com and other CARE publications. 1 CARE Ratings Limited Press Release CARE has withdrawn the ratings assigned to the NCD issues of Jindal Steel and Power Limited with immediate effect, as the company has repaid the NCD issues in fu

CARE rationale
06 Jul 2021 ₹673 cr raised through equity
From the report

The promoters of the company have demonstrated their support in form of regular equity infusions; more recently through a qualified institutional p lacement (QIP) in FY18 of Rs. 1,200 crore followed by issue of share warrants to promoters of Rs. 673 crore (issued in FY18 with 25% upfront receipt and converted into equity share in FY20 with receipt of remaining 75%) and fresh equity infusion of Rs 20 c rore.

CARE rationale
06 Jul 2021 Cash & liquid funds ₹12,334 cr
From the report

Liquidity: Strong JSPL’s liquidity position improved and stood strong marked by healthy cash accruals of Rs. 12,334 crore during FY21 (PY: Rs. 3,731 crore) and free cash and cash equivalent of ~Rs 7,000 crore as on March 31, 2021.

CARE rationale
06 Jul 2021 Cash & liquid funds ₹12,600 cr
From the report

The company expects gross cash accruals of ~Rs. 12,600 crore against scheduled debt repayment obligation of Rs. 6861 crore (excl .

CARE rationale
06 Jul 2021 Debt repayments due: ₹6,861 cr
From the report

The company expects gross cash accruals of ~Rs. 12,600 crore against scheduled debt repayment obligation of Rs. 6861 crore (excl .

CARE rationale
06 Jul 2021 Full repayment of debt (₹1,250 cr)
From the report

Free cash and cash equivalent of the company after making the payment of instalment of JSPML in April and prepayment of debt in May and June, 2021 stood at ~Rs. 1 ,650 crore as on June 2 6, 2021, while the unutilized CC limit was of ~Rs. 1250 crore.

CARE rationale
06 Jul 2021 Average working-capital utilisation 40%
From the report

Average fund based working capital utilization of the company stood low at ~40% for the trailing 12 months ended May, 2021.

CARE rationale
06 May 2021 CARE reaffirmed: A- (Stable)Rated limits ₹50,976.28 cr CARE rationale
06 May 2021 ₹693 cr raised through equity
From the report

The promoters of the company have demonstrated their support in form of regular equity infusions; more recently through a qualified institutional placement (QIP) in FY18 of Rs. 1,200 crore followed by issue of share warrants to promoters of Rs. 693 crore in FY18 and FY20.

CARE rationale
01 Apr 2021 CARE revised: A2+ (Stable)Rated limits ₹50,976.28 cr CARE rationale
01 Apr 2021 ₹693 cr raised through equity
From the report

The promoters of the company have demonstrated 2 CARE Ratings Limited Press Release their support in form of regular equity infusions; more recently through a qualified institutional placement (QIP) in FY18 of Rs. 1,200 crore followed by issue of share warrants to promoters of Rs. 693 crore in FY18 and FY20.

CARE rationale
30 Dec 2020 CARE revised: BBB+ (Stable)Rated limits ₹519.8 cr CARE rationale
30 Dec 2020 ₹693 cr raised through equity
From the report

The promoters of the company have demonstrated their support in form of regular equity infusions; more recently through a qualified institutional placement (QIP) in FY18 of Rs. 1,200 crore followed by issue of share warrants to promoters of Rs. 693 crore in FY18 and FY20.

CARE rationale
30 Dec 2020 Cash & liquid funds ₹498.3 cr
From the report

Free cash and cash equivalents as on September 30, 2020 stood at Rs. 498.30 crore (March 31, 2020: Rs. 744.91 crore) Analytical approach: CARE has adopted a consolidated approach on account of operational and financial linkages among the entities.

CARE rationale
06 Jul 2020 CARE watch: BBB (Stable)Rated limits ₹24,971.23 cr CARE rationale
06 Jul 2020 ₹693 cr raised through equity
From the report

The promoters of JSPL have demonstrated their support in form of regular equity infusions, more recently through a qualified institutional placement (QIP) in FY18 (refers to the period: April 01, 2017 to March 31, 2018) of Rs. 1,200 crore followed by issue of share warrants to promoters of Rs. 693 crore in FY18 and FY20.

CARE rationale
06 Jul 2020 Cash & liquid funds ₹744.91 cr
From the report

Free cash and cash equivalents as on March 31, 2020 stood at Rs. 744.91 crore (PY: Rs. 329.30 crore).

CARE rationale
06 Jul 2020 Rated term loans fell from ₹1,447.19 cr to ₹0 cr CARE rationale
17 Apr 2020 CARE watch: BBB-Rated limits ₹25,169.65 cr CARE rationale
17 Apr 2020 Full repayment of loans
From the report

JSPL has opted for moratorium on the repayment of loans to its lenders till May 31, 2020.

CARE rationale
30 Aug 2019 CARE reaffirmed: BBB- (Stable)Rated limits ₹25,169.65 cr CARE rationale
30 Aug 2019 Cash & liquid funds ₹3,136 cr
From the report

Liquidity position: JSPL has adequate liquidity position on a standalone basis marked by gross cash accruals of Rs.3,136 crore during FY19 as against gross loan repayments of Rs.2,105 crore during FY20.

CARE rationale
30 Aug 2019 ₹505 cr raised through equity
From the report

Besides cash accruals, the liquidity position is supported by equity infusion of Rs.505 crore during Q1FY20 and undrawn lines albeit high utilization of fund based limits which stood at 92% for trailing 12 months ended May 2019.

CARE rationale
30 Aug 2019 Rated term loans fell from ₹1,500 cr to ₹0 cr CARE rationale
08 Feb 2019 CARE reaffirmed: BBB- (Stable)Rated limits ₹25,001.78 cr CARE rationale
08 Feb 2019 Cash & liquid funds ₹2,675 cr
From the report

Liquidity The company has generated healthy cash accruals of Rs.2,675 crore during 9MFY19 against which it has full year repayments of Rs.1,859 crore.

CARE rationale
08 Feb 2019 Cash & liquid funds ₹217.85 cr
From the report

The company’s liquidity position is further supported by cash and cash equivalent of Rs.217.85 crore as on September 30, 2018.

CARE rationale
08 Feb 2019 Average working-capital utilisation 92.73%
From the report

Further, the average working capital utilization remained at 92.73% over the past eleven months ended November 2018.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeO.P. JINDAL MARG, HISAR, IN-HR, 125005
GSTIN—
Email—
Websitehttps://www.jindalsteel.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Jindal Steel

Competitors10identified
Locations3most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Tata Steel Steel tatasteel.com 1907 Mumbai, Global
JSW Steel Steel jsw.in 1982 Mumbai, Global
SAIL Steel sail.co.in — Salem, Global
Iron Edge Gateway TMT Bars & Secondary Steel · Steel, Metals & Pipes entropya.com/ieg-router — Global
Nucor TMT Bars & Secondary Steel · Steel, Metals & Pipes nucor.com — United States
Steel Dynamics TMT Bars & Secondary Steel · Steel, Metals & Pipes steeldynamics.com 1996 United States
Carpenter Technology Corporation TMT Bars & Secondary Steel · Steel, Metals & Pipes cartech.com — United States
Cleveland Cliffs TMT Bars & Secondary Steel · Steel, Metals & Pipes clevelandcliffs.com — United States
Commercial Metals Company TMT Bars & Secondary Steel · Steel, Metals & Pipes cmc.com — United States
Surya Roshni Pipes & Tubes · Steel, Metals & Pipes surya.co.in — Bahadurgarh, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.